Humanin suppresses receptor activator of nuclear factor-КB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation

Research output: Contribution to journalArticle

Abstract

Humanin (HN) is a mitochondrial peptide that exhibits cytoprotective actions against various stresses and diseases. HN has been shown to induce the phosphorylation of AMP-activated protein kinase (AMPK), which is a negative regulator of receptor activator of nuclear factor-КB ligand (RANKL). However, the role of HN in osteoclastogenesis or other skeletal disorders remains unknown. Here, we examined whether HN regulates osteoclastogenesis via AMPK activation using bone marrow-derived macrophage (BMM) cultures. Our results show that HN inhibited RANKL-induced osteoclast formation and reduced the expression of genes involved in osteoclastogenesis, including nuclear factor of activated T-cells cytoplasmic 1, osteoclast-associated receptor, cathepsin K, and tartrate-resistant acid phosphatase. Moreover, HN increased the levels of phosphorylated AMPK protein; compound C, an AMPK inhibitor, recovered HN-induced osteoclast differentiation. In addition, we found that HN significantly decreased the levels of RANKL-induced reactive oxygen species in BMMs. Therefore, these results indicate that HN plays an important role in osteoclastogenesis and may function as an inhibitor of bone disorders via AMPK activation.

Original languageEnglish
Pages (from-to)411-417
Number of pages7
JournalKorean Journal of Physiology and Pharmacology
Volume23
Issue number5
DOIs
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology

Fingerprint Dive into the research topics of 'Humanin suppresses receptor activator of nuclear factor-КB ligand-induced osteoclast differentiation via AMP-activated protein kinase activation'. Together they form a unique fingerprint.

Cite this